Table 1 Demographics, headache severity, and comorbidities
|  | NDPH (n = 366) | T-CDH (n = 696) |
|---|---|---|
Age (mean ± SD) | 37.9 ± 14.4 | 40.3 ± 15.2 |
Sex, females (frequency, percentage) | 229 (62.6%) | 510 (73.3%) |
Headache frequency, days per month (mean ± SD) | 28 ± 0 | 28 ± 0 |
Headache intensity, 0–10 scale (mean ± SD) | 7.65 ± 1.63 | 8.15 ± 1.32 |
Medication overuse | 57 (15.6%) | 293 (42.1%) |
Clinical diagnosis of depression | 74 (20.2%) | 166 (23.8%) |
Clinical diagnosis of anxiety | 58 (15.8%) | 122 (17.5%) |
Clinical diagnosis of joint hypermobility syndrome | 41 (11.2%) | 129 (18.5%) |
HIT 6 | n = 278 | n = 517 |
Median score (range) | 67 (36–78) | 67 (36–78) |
Proportion in severe impact range (score ≥ 60) | 242 (87.1%) | 471 (91.1%) |
MIDAS | N = 273 | N = 493 |
Median score (range) | 90 (0–270) | 84 (0–270) |
Proportion in severe impact range (score ≥ 21) | 238 (87.2%) | 430 (87.2%) |
HADS-A | N = 282 | N = 518 |
Median score (range) | 8 (0–21) | 9 (0–21) |
Proportion in abnormal range (score ≥ 11) | 100 (35.5%) | 204 (39.4%) |
HADS-D | N = 282 | N = 520 |
Median score (range) | 8 (0–21) | 8 (0–21) |
Proportion in abnormal range (score ≥ 11) | 110 (39.0%) | 167 (32.1%) |